BlackRock, Inc. 13D and 13G filings for FibroGen, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-07-08 4:32 pm Sale | 2024-06-30 | 13G | FibroGen, Inc. FGEN | BlackRock Inc. BLK | 96,386 2.400% | -191,826 (-66.56%) | Filing |
| 2024-01-26 4:23 pm Purchase | 2023-12-31 | 13G | FibroGen, Inc. FGEN | BlackRock Inc. BLK | 288,212 7.300% | 2,862 (+1.00%) | Filing |
| 2023-02-06 12:37 pm Purchase | 2022-12-31 | 13G | FibroGen, Inc. FGEN | BlackRock Inc. BLK | 285,350 7.600% | 19,528 (+7.35%) | Filing |
| 2022-02-01 5:08 pm Sale | 2021-12-31 | 13G | FibroGen, Inc. FGEN | BlackRock Inc. BLK | 265,822 7.200% | -50,082 (-15.85%) | Filing |
| 2021-01-29 09:56 am Purchase | 2020-12-31 | 13G | FibroGen, Inc. FGEN | BlackRock Inc. BLK | 315,904 8.700% | 50,824 (+19.17%) | Filing |